Lee Hood, M.D., Ph.D.

Lee Hood, M.D., Ph.D.

Lee Hood, M.D., Ph.D.

Co-Founder & Board Member, Indi
Co-Founder & President, Institute for Systems Biology

Lee Hood, M.D., Ph.D., is an unparalleled pioneer in the translation of technology from R&D to industry. He has co-founded more than 14 biotechnology companies, including Amgen, Applied Biosystems, Systemix, Darwin and Rosetta. Amgen and Applied Biosystems have a combined market capitalization of over $50B.

Dr. Hood is a member of the National Academy of Sciences, the American Philosophical Society, the American Academy of Arts and Sciences, the Institute of Medicine and the National Academy of Engineering. He is one of only 10 members out of more than 6000 that are in all three US National Academies (NAS, IOM, and NAE).

In 2012 Dr. Hood received the National Medal of Science, the highest honor awarded scientists by the United States government. He is also the 2011 recipient of the Russ Prize, awarded by the National Academy of Engineering, for his development of the automated DNA sequencer–a tool that has revolutionized biomedicine and forensic science. In addition, he is the recipient of numerous other major awards including the Lasker Award, the Kyoto Prize, and the Lemelson-MIT Prize. Dr. Hood has over 700 publications, 26 patents and has written multiple textbooks in diverse areas.

In addition to being a co-founder of Indi, Dr. Hood was a co-founder of the Seattle-based Institute for Systems Biology. He is also the co-founder of Indi Molecular, which was spun-out from its parent company Indi (Integrated Diagnostics) in 2013.

 
You are now leaving this website. If you would like to continue, click Continue.
Cancel Continue